Scientists have identified a naturally occurring compound in broccoli that may help combat Friedreich ataxia, a rare and devastating genetic disorder that progressively damages the nervous system. According to the research findings, the compound works by boosting a vital protein and protecting nerve cells from deterioration, offering a potential new avenue for treatment. Friedreich ataxia currently has limited therapeutic options, and the discovery has raised hopes among researchers and patient advocates for an accessible and affordable intervention.
The research team cautioned that clinical trials are still required to establish the compound's effectiveness in human patients, and no timeline for such trials has been announced. While the early findings are promising, experts not involved in the study noted that results observed at the cellular level do not always translate into clinical benefit. The scientists behind the discovery emphasized that any future treatment derived from the compound would need to undergo rigorous safety and efficacy testing before reaching patients. Further details are expected to be published in a peer-reviewed journal.
Independent reporting synthesized from primary wires and global correspondents.